ARTIVION INC (AORT) Stock Price, Quote, News and Overview
NYSE:AORT - New York Stock Exchange, Inc. - US2289031005 - Common Stock - Currency: USD
AORT Quote, Performance and Key Statistics
28.71
-0.87 (-2.94%)
The current stock price of AORT is 28.71 USD. In the past month the price increased by 23.06%. In the past year, price increased by 23.01%.
AORT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.94 | 232.39B | ||
| ISRG | INTUITIVE SURGICAL INC | 72.42 | 198.31B | ||
| BSX | BOSTON SCIENTIFIC CORP | 38.58 | 154.11B | ||
| SYK | STRYKER CORP | 30.4 | 145.55B | ||
| MDT | MEDTRONIC PLC | 15.23 | 107.40B | ||
| BDX | BECTON DICKINSON AND CO | 12.02 | 48.55B | ||
| EW | EDWARDS LIFESCIENCES CORP | 30.04 | 45.81B | ||
| IDXX | IDEXX LABORATORIES INC | 45.16 | 41.72B | ||
| RMD | RESMED INC | 26.88 | 35.78B | ||
| DXCM | DEXCOM INC | 51.82 | 33.53B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.25 | 32.12B | ||
| STE | STERIS PLC | 25.92 | 23.78B |
Related stock screener links
About AORT
Company Profile
Artivion, Inc. engages in the research and development of solutions which address cardiac and vascular surgeons' clinical challenges in treating patients with aortic diseases. The company is headquartered in Kennesaw, Georgia and currently employs 1,600 full-time employees. The firm is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
Company Info
ARTIVION INC
1655 Roberts Boulevard N W
Kennesaw GEORGIA US
Employees: 1600
Phone: 17704193355
ARTIVION INC / AORT FAQ
What is the stock price of ARTIVION INC today?
The current stock price of AORT is 28.71 USD. The price decreased by -2.94% in the last trading session.
What is the ticker symbol for ARTIVION INC stock?
The exchange symbol of ARTIVION INC is AORT and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is AORT stock listed?
AORT stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for ARTIVION INC stock?
12 analysts have analysed AORT and the average price target is 32.98 USD. This implies a price increase of 14.87% is expected in the next year compared to the current price of 28.71. Check the ARTIVION INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ARTIVION INC worth?
ARTIVION INC (AORT) has a market capitalization of 1.23B USD. This makes AORT a Small Cap stock.
How many employees does ARTIVION INC have?
ARTIVION INC (AORT) currently has 1600 employees.
What are the support and resistance levels for ARTIVION INC (AORT) stock?
ARTIVION INC (AORT) has a support level at 28.68 and a resistance level at 29.15. Check the full technical report for a detailed analysis of AORT support and resistance levels.
Is ARTIVION INC (AORT) expected to grow?
The Revenue of ARTIVION INC (AORT) is expected to grow by 9.01% in the next year. Check the estimates tab for more information on the AORT EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ARTIVION INC (AORT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AORT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AORT, evaluating the profitability, health, valuation and growth aspects
- ARTIVION INC (AORT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ARTIVION INC (AORT) Sales and EPS estimates to see what analysts future expectations are.
- ARTIVION INC (AORT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ARTIVION INC (AORT) Insider and Institutional Ownership to learn about the owners and their transactions.
- ARTIVION INC (AORT) Stock Chart to make your own analysis
- ARTIVION INC (AORT) Latest news and press-releases to stay up to date.
Does ARTIVION INC (AORT) stock pay dividends?
AORT does not pay a dividend.
When does ARTIVION INC (AORT) report earnings?
ARTIVION INC (AORT) will report earnings on 2025-08-06, after the market close.
What is the Price/Earnings (PE) ratio of ARTIVION INC (AORT)?
ARTIVION INC (AORT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.5).
What is the Short Interest ratio of ARTIVION INC (AORT) stock?
The outstanding short interest for ARTIVION INC (AORT) is 11.52% of its float. Check the ownership tab for more information on the AORT short interest.
AORT Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to AORT. When comparing the yearly performance of all stocks, AORT is one of the better performing stocks in the market, outperforming 87.18% of all stocks.
AORT Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to AORT. AORT has an average financial health and profitability rating.
AORT Financial Highlights
Over the last trailing twelve months AORT reported a non-GAAP Earnings per Share(EPS) of -0.5. The EPS decreased by -42.86% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.7% | ||
| ROE | -7.26% | ||
| Debt/Equity | 1.08 |
AORT Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 87% to AORT. The Buy consensus is the average rating of analysts ratings from 12 analysts.
For the next year, analysts expect an EPS growth of 122.93% and a revenue growth 9.01% for AORT